The role of 18FDG-PET/CT for response assessment after (chemo)radiotherapy for head and neck squamous cell carcinoma

被引:0
|
作者
Van den Heuvel, B. [1 ,2 ]
Roothans, D. [1 ,2 ]
Helsen, N. [2 ]
Van den Wyngaert, T. [2 ]
Van den Weyngaert, D. [1 ,3 ]
Carp, L. [2 ]
Stroobants, S. [1 ,2 ]
机构
[1] Univ Antwerp, B-2020 Antwerp, Belgium
[2] Univ Antwerp Hosp, Dept Nucl Med, Edegem, Belgium
[3] ZNA Middelheim, Dept Radiotherapy, Antwerp, Belgium
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
引用
收藏
页码:S251 / S251
页数:1
相关论文
共 50 条
  • [41] Serial 18F-FDG CT-PET scans during radical radiotherapy inpatients with squamous cell carcinoma of the head and neck
    Moule, R. N.
    Kayani, I.
    Saunders, M. I.
    ORAL ONCOLOGY, 2009, : 235 - 236
  • [42] DIAGNOSTIC PERFORMANCE OF RESPONSE ASSESSMENT FDG-PET/CT IN PATIENTS WITH HEAD & NECK SQUAMOUS CELL CARCINOMA TREATED WITH HIGH-PRECISION DEFINITIVE (CHEMO)RADIATION
    Gupta, T.
    Jain, S.
    Agarwal, J. P.
    Rangarajan, V.
    Ghosh-Laskar, S.
    Dinshaw, K.
    Purandare, N.
    RADIOTHERAPY AND ONCOLOGY, 2010, 94 : S27 - S28
  • [43] Diagnostic performance of response assessment FDG-PET/CT in patients with head and neck squamous cell carcinoma treated with high-precision definitive (chemo)radiation
    Gupta, Tejpal
    Jain, Sandeep
    Agarwal, Jai Prakash
    Rangarajan, Venkatesh
    Purandare, Nilendu
    Ghosh-Laskar, Sarbani
    Dinshaw, Ketayun A.
    RADIOTHERAPY AND ONCOLOGY, 2010, 97 (02) : 194 - 199
  • [44] Role of 18F-FDG PET/CT in evaluating lymph node status in patients with head and neck squamous cell carcinoma
    Bianchini, Chiara
    Caracciolo, Matteo
    Urso, Luca
    Ciorba, Andrea
    Bonsembiante, Anna
    Migliorelli, Andrea
    Corazzi, Virginia
    Carandina, Ilaria
    Ortolan, Naima
    Cittanti, Corrado
    Uccelli, Licia
    Pelucchi, Stefano
    Panareo, Stefano
    Bartolomei, Mirco
    ACTA OTORHINOLARYNGOLOGICA ITALICA, 2023, 43 (04) : 235 - 244
  • [45] Diagnostic Value of Surveillance 18F-FDG PET/CT in Head and Neck Squamous Cell Carcinoma After Curative Therapy
    Whi, Wonseok
    Moon, Seung Hwan
    Oh, Dongryul
    Chung, Man Ki
    Jeong, Han-Sin
    Ahn, Myung Ju
    Choi, Joon Young
    CLINICAL NUCLEAR MEDICINE, 2025, 50 (04) : 301 - 306
  • [46] 18F-FDG-PET/CT-based treatment planning for definitive (chemo) radiotherapy in patients with head and neck squamous cell carcinoma improves regional control and survival
    van den Bosch, Sven
    Doornaert, Patricia A. H.
    Dijkema, Tim
    Zwijnenburg, Ellen M.
    Verhoef, Lia C. G.
    Hoeben, Bianca A. W.
    Kasperts, Nicolien
    Smid, Ernst J.
    Terhaard, Chris H. J.
    Kaanders, Johannes H. A. M.
    RADIOTHERAPY AND ONCOLOGY, 2020, 142 : 107 - 114
  • [47] FDG-PET/CT in the assessment of retro- and parapharyngeal metastases in head and neck squamous cell carcinoma
    Siepmann, S.
    Broemme, J.
    Arnold, A.
    Schmuecking, M.
    Giger, R.
    Aebersold, D.
    Krause, T.
    Klaeser, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 : S251 - S251
  • [48] Lipid metabolism marker CD36 is associated with 18FDG-PET/CT false negative lymph nodes in head and neck squamous cell carcinoma
    Meng, Xiaoyan
    Sun, Jingjing
    Xu, Feng
    Liu, Zhonglong
    He, Yue
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [49] Predictive value of quantitative diffusion-weighted imaging and 18-F-FDG-PET in head and neck squamous cell carcinoma treated by (chemo) radiotherapy
    Marten, Roland M.
    Noij, Daniel P.
    Koopman, Thomas
    Zwezerijnen, Ben
    Heymans, Martijn
    de Jong, Marcus C.
    Hoekstra, Otto S.
    Vergeer, Marije R.
    de Bree, Remco
    Leemans, C. Rene
    de Graaf, Pim
    Boellaard, Ronald
    Castelijns, Jonas A.
    EUROPEAN JOURNAL OF RADIOLOGY, 2019, 113 : 39 - 50
  • [50] Accuracy of response assessment FDG PET-CT post-(chemo)radiotherapy in HPV-negative oropharynx squamous cell carcinoma
    Ebozue, Zsuzsanna Iyizoba
    Billingsley, Sarah
    Frood, Russell
    Vaidyanathan, Sriram
    Scarsbrook, Andrew
    Prestwich, Robin
    CLINICAL ONCOLOGY, 2022, 34 : E19 - E19